Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (2)
Article
Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MorePress Release
Express Scripts Further Advances Transparency and Affordability for Consumers and Clients
April 13, 2023
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...